Flexbone vs SamaCare

At a Glance

The Core Difference: Drug PA Point Solution vs Full Back Office

The honest comparison between Flexbone and SamaCare is about scope, not price.

SamaCare answers: "How do we get medical-benefit drug PAs off our staff without writing a check?"

Flexbone answers: "How do we automate the full back office of a specialty practice, including PA across all categories, eligibility, denials, and voice, with one accountable platform?"

SamaCare is genuinely useful for the slice of work it covers. For an oncology practice running dozens of medical-benefit drug PAs per week, an oncology nurse no longer has to log into seven payer portals or wait on hold; SamaCare's interface and pharma-supplied resources compress that workflow. Practices that have adopted it routinely report meaningful relief on the drug PA queue.

The gap is everything else. Specialty practices also run prior auth for procedures (orthopedic surgery, GI endoscopy, ophthalmology surgery), imaging (MRI, CT), and DME. They run eligibility verification on each scheduled patient. They process denial letters across the entire revenue cycle. They take and make patient phone calls all day. SamaCare does not work on any of that. If a specialty practice has 100 hours per week of back-office staff time, drug PA is one bucket inside it.

Flexbone is built to address the bucket and the whole back office in one platform. The PA work covers drugs, procedures, imaging, and DME. Eligibility and denials run on the same data layer. Voice agents handle scheduling and outbound recall. The point is consolidation: one ops platform that staff and RCM leaders can actually hold accountable for outcomes across the practice.

Funding Model: Pharma-Subsidized vs Practice-Paid

SamaCare's "free for practices" model is real, and it deserves a straightforward treatment.

SamaCare is funded by pharmaceutical manufacturers. The platform is offered at no cost to provider practices, and the business model is built on relationships with drugmakers who benefit when their products are prescribed and approved through PA more efficiently. The 2023 AmerisourceBergen (Cencora) distribution arrangement extended that reach into specialty practices that work with the wholesaler.

For some practices this is fine. The workflow value is real, the cost is zero, and the platform does what it says. For others, the arrangement is structurally uncomfortable, particularly for groups that:

• Want their PA tooling to be drug-agnostic and free of any pharmaceutical sponsor incentives
• Have hospital, MSO, or private-equity owners with policy positions on pharma-funded vendor relationships
• Need PA to cover non-drug categories (procedures, imaging, DME) where pharma funding does not apply
• Prefer a single accountable vendor with a paid relationship rather than a sponsored platform whose economics live elsewhere

Flexbone is paid directly by the practice. The economic relationship is straightforward: the practice contracts Flexbone, Flexbone is accountable for the outcomes, and there is no third party in the loop. For RCM and compliance leaders who want clean vendor economics, that simplicity matters.

The comparison is not "free vs expensive." It is "sponsored point solution" vs "paid horizontal platform with one accountable vendor." Different teams will weigh those tradeoffs differently.

Feature Comparison

Prior Authorization Scope

This is the most important part of the comparison for specialty practices evaluating both tools.

SamaCare focuses on medical-benefit drug PA: biologics, infusions, injectables, and other clinician-administered drugs billed under the medical benefit. The product is deeply tuned to the workflows in oncology, rheumatology, neurology, gastroenterology, and ophthalmology where these drugs drive significant PA volume. SamaCare supplies payer-specific PA forms, electronic submission where supported, and status tracking.

Flexbone runs prior authorization across the full range of categories a specialty practice encounters:

• Medical-benefit drugs: Same category SamaCare covers, including biologics, infusions, and intravitreal injections.
• Procedures and surgical PA: Orthopedic surgery, GI endoscopy, ophthalmology surgery, ENT, urology, podiatry, and other procedural specialties.
• Imaging: MRI, CT, PET, nuclear medicine, and other high-cost imaging PAs.
• DME: Durable medical equipment auth, including the documentation and certificate of medical necessity workflows that are uniquely time-intensive.

For an MSO running multiple specialties under one operational umbrella, the difference is consequential. SamaCare addresses the drug PA queue for the specialties that have one. Flexbone addresses the full PA queue across every specialty in the group.

Eligibility Verification

SamaCare does not run eligibility verification.

Flexbone EVOB runs eligibility checks across three channels (270/271 EDI, payer portal scraping, payer IVR) and reconciles the results into one canonical eligibility record per patient. It calculates accurate patient responsibility using real-time benefits, copay tiers, and deductible status. Customers have reported a 30% reduction in eligibility-related denials, which directly addresses one of the largest preventable causes of denials in specialty practice billing.

For practices where eligibility is currently being done by hand or where 270/271 alone returns thin or unreliable data on specialty benefits, this is a workflow that SamaCare simply does not address.

Denials Management

SamaCare does not run denials.

Flexbone AI Denials Management ingests denial letters in any format (EDI 835, paper, fax, PDF), extracts the reason codes using OCR and NLP, drafts appeals, and submits corrected claims back through the clearinghouse. The system creates Revenue Management Tasks that route to the right staff member when human review is required.

For a specialty practice running on tight margins, the denial workflow is where money leaks out of the back office. Drug PA prevents some denials at the front end. Active denials management recovers the money that still gets denied despite good PA.

Voice and Patient Coordination

SamaCare is a portal product; there is no voice agent layer.

Flexbone runs both inbound and outbound voice through healthcare calls, with specialty-specific tuning for high-volume call workflows like orthopedic calls and dental and oral surgery. Voice agents handle scheduling, recall, confirmation, refill triage, and outbound eligibility follow-up to payers. The AI Patient Coordinator consolidates inbound conversations across calls, web forms, WhatsApp, and social messages.

Voice Room adds analytics: 100% of inbound calls are transcribed and analyzed, surfacing recurring issues (billing confusion, scheduling friction, drop reasons) that no human QA team can review at scale.

If a specialty practice's biggest operational bottleneck is phone load, SamaCare does not address it. Flexbone does.

EHR Integration

Both products integrate with specialty EHRs. The depth differs.

SamaCare integrates with major specialty EHRs used in oncology, rheumatology, neurology, GI, and ophthalmology. Integration depth varies by practice and by EHR; for some, SamaCare runs as a side-portal workflow rather than embedded inside the EHR.

Flexbone runs forward-deployed integrations with 15+ EHRs covering specialty groups, ASCs, SNFs, and dental DSOs. The integration model is custom-built to the practice's actual EHR setup rather than off-the-shelf connectors. The named systems include ModMed (EMA and gGastro), athenahealth, eClinicalWorks, NextGen, AdvancedMD, Greenway, Tebra, ASC systems (HST, SIS), SNF systems (PointClickCare), and dental systems (Dentrix, Open Dental, Eaglesoft).

Security Comparison

Both products are HIPAA compliant. They handle PHI in different operational contexts.

SamaCare is HIPAA compliant. Because the platform handles PA submissions across payers and drug manufacturers, data flows include clinical context (diagnosis, treatment plan, lab values) that supports the medical necessity argument. Patient data is retained as part of the PA record.

Flexbone is HIPAA compliant, SOC 2 certified, and adds zero-retention: PHI is processed to take action and then discarded. No patient data is stored on Flexbone systems after the workflow completes. For RCM workflows where retention is not required after action (eligibility checks, claim corrections, appeal submission), zero-retention eliminates an entire breach-risk category.

The architectural distinction reflects how the products are funded and operated. A pharma-funded PA platform necessarily integrates with manufacturer programs and retains supporting clinical context. An independent paid platform can choose not to retain PHI when the workflow does not require it.

Pricing Comparison

SamaCare is free for provider practices. The platform is funded by pharmaceutical manufacturers and distribution partners. There is no direct cost to the practice for using SamaCare for medical-benefit drug PAs.

Flexbone uses custom pricing tied to operational scope: PA volume across categories, eligibility transactions, denial workload, voice load, and number of EHRs integrated. Outcome-aligned pricing means the practice pays for measurable back-office automation results. Customers have reported $250,000+ per year in operational savings on larger deployments. The ROI calculator can size impact against current AR aging, denial rate, and staff hours per PA.

The comparison that matters is total back-office cost, not vendor invoice. A practice running SamaCare for drug PA still has staff doing eligibility by hand, denials by hand, and phone work by hand. A practice running Flexbone consolidates all of that work into one platform with one accountable vendor. The right way to evaluate is to size the full operational cost (staff hours plus tooling) and compare like-for-like.

Who Should Choose Flexbone

Multi-specialty groups and MSOs. If the group runs more than one specialty under one operations team, Flexbone's PA scope covers procedures, imaging, and DME alongside drugs. SamaCare only covers the drug slice.

RCM directors with denial pain. If the largest revenue cycle problem is denials rather than (or in addition to) drug PA, Flexbone's denials management is built for that. SamaCare does not address denials.

Practices with eligibility load. If eligibility checks are still being run manually or through unreliable 270/271 alone, Flexbone's multi-channel eligibility verification is one of the highest-ROI workflows we run. SamaCare does not cover eligibility.

Specialty groups with heavy call volume. Orthopedics, ophthalmology, dermatology, GI, dental DSOs: Flexbone voice addresses the phone layer that a portal-based PA tool cannot.

Practices that want clean vendor economics. If your organization has a policy preference for paid, accountable vendor relationships rather than pharma-sponsored tooling, Flexbone's direct paid model is structurally simpler.

ASCs and SNFs. Flexbone integrates with ASC systems (HST, SIS) and SNF systems (PointClickCare) where PA, eligibility, and denials all share the same operational team. SamaCare's footprint in these environments is thinner.

Contact Flexbone to scope the workflow against your current PA, eligibility, and denial volumes. The provider contact transformation overview shows how the voice and back-office layers connect inside one platform.

Who Should Choose SamaCare

Single-specialty practices where drug PA is the dominant workflow. If your operations are concentrated in oncology, rheumatology, neurology, GI, or ophthalmology, drug PA is a heavy queue and SamaCare is purpose-built for it.

Practices comfortable with pharma-funded tooling. If the pharma sponsorship model is operationally acceptable and the workflow value is what matters, SamaCare delivers real benefit at zero direct cost.

Practices that have already solved everything else. If eligibility and denials are running cleanly, the phones are under control, and the only remaining bottleneck is drug PA, SamaCare can plug into that one workflow without expanding scope.

Smaller specialty practices. SamaCare's lack of integration ceremony makes it easy for smaller practices to adopt for drug PA specifically, without the broader procurement and integration work a horizontal platform requires.

Practices with manufacturer-specific PA programs. Because SamaCare is funded by pharma and partnered with distribution channels, manufacturer-specific PA programs (patient support, copay assistance, etc.) flow naturally into the platform.